Please assess the completion status of the following clinical trial:

Trial Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of TRD~Exclusion Criteria:~* Other comorbidities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low dose (Type: EXPERIMENTAL): Low dose Psilocybin
- Medium dose (Type: EXPERIMENTAL): Medium dose Psilocybin
- High dose (Type: EXPERIMENTAL): High dose Psilocybin

Based on this trial design, predict the completion outcome and termination type (if applicable).